Human papillomavirus-related oropharyngeal carcinoma.

Alphapapillomavirus Carcinoma, Squamous Cell / pathology Head and Neck Neoplasms Humans Oropharyngeal Neoplasms / pathology Papillomaviridae Papillomavirus Infections / complications Papillomavirus Vaccines / therapeutic use Quality of Life
HNSCC Japan human papillomavirus oropharyngeal carcinoma p16

Journal

Japanese journal of clinical oncology
ISSN: 1465-3621
Titre abrégé: Jpn J Clin Oncol
Pays: England
ID NLM: 0313225

Informations de publication

Date de publication:
08 07 2022
Historique:
received: 28 09 2021
accepted: 19 03 2022
pubmed: 7 4 2022
medline: 12 7 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

It was not until around 2000 that human papillomavirus-related oropharyngeal carcinoma was recognized as carcinoma with clinical presentations different from nonrelated head and neck carcinoma. Twenty years after and with the revision of the tumor-node-metastasis classification in 2017, various clinical trials focused on human papillomavirus-related oropharyngeal carcinoma to improve the prognosis and quality of life of patients with this disease. However, the incidence of human papillomavirus-related cancers is increasing, which is expected to be particularly prominent in Japan, where human papillomavirus vaccination is not widely available. In this review, we describe the current status of clinical trials (mainly focused on initial surgery and radiation dose reduction) for, primary and secondary prevention of, and the present status of human papillomavirus-related oropharyngeal carcinoma in Japan.

Identifiants

DOI: 10.1093/jjco/hyac049 PMID: 35383359
pubmed: 35383359
pii: 6563948
doi: 10.1093/jjco/hyac049
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

700-706

Subventions

Organisme : National Cancer Center Research and Development
ID : 2020-J-3

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Yuki Saito (Y)

Department of Otolaryngology and Head and Neck Surgery, University of Tokyo, Tokyo, Japan.
ORCID: 0000-0002-4825-7783

Akihiro Homma (A)

Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Naomi Kiyota (N)

Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan.

Makoto Tahara (M)

Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

Nobuhiro Hanai (N)

Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Takahiro Asakage (T)

Department of Head and Neck Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Kazuto Matsuura (K)

Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Ichiro Ota (I)

Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Nara, Japan.
ORCID: 0000-0003-3815-8877

Tomoya Yokota (T)

Divisions of Gastrointestinal Oncology, Shizuoka Cancer Center, Kashiwa, Japan.
ORCID: 0000-0001-7327-7949

Daisuke Sano (D)

Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Takeshi Kodaira (T)

Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.

Atsushi Motegi (A)

Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

Koichi Yasuda (K)

Department of Radiation Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.

Shunji Takahashi (S)

Department of Medical Oncology, Cancer Institute Hospital, Tokyo, Japan.
ORCID: 0000-0002-5031-1953

Kaoru Tanaka (K)

Department of Medical Oncology, Kindai University Faculty of Medicine, Higashi-Osaka, Japan.

Takuma Onoe (T)

Division of Medical Oncology, Hyogo Cancer Center, Hyogo, Japan.

Susumu Okano (S)

Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
ORCID: 0000-0001-6639-9753

Yoshinori Imamura (Y)

Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan.
ORCID: 0000-0002-5202-531X

Yosuke Ariizumi (Y)

Department of Head and Neck Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Ryuichi Hayashi (R)

Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Virus › Virus oncogènes › Virus tumoraux à ADN › Papillomaviridae › Alphapapillomavirus › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs épidermoïdes › Carcinome épidermoïde › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Maladies oto-rhino-laryngologiques › Maladies du pharynx › Tumeurs du pharynx › Tumeurs de l'oropharynx › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Virus › Virus oncogènes › Virus tumoraux à ADN › Papillomaviridae › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies transmissibles › Maladies sexuellement transmissibles › Maladies sexuellement transmissibles virales › Infections à papillomavirus › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre les papillomavirus › Human papillomavirus-related oropharyngeal carcinoma.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Human papillomavirus-related oropharyngeal carcinoma.